Changed indices of the humoral and cellular immunity in patients with chronic 15 hepatitis С of different severity
- Issue: Vol 48, No 3 (2003)
- Pages: 15-19
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.06.2003
- URL: https://virusjour.crie.ru/jour/article/view/11772
- ID: 11772
Cite item
Full Text
Abstract
The purpose of the present study was to investigate the influence produced by viral proteins in the hepatic cells and RNA of hepatitis С virus (HCV) on the indices of T- and B-cell response in 52 patients with chronic hepatitis С (СНС). A relative count of peripheral-blood lymphocytes (PBL), expressing antigens CD3*, CD4*, CD8*, CD16*, CD20* and CD95* was estimated. The repertoire of antibodies to HCV proteins was specified. The thus obtained data were compared with an activity and a disease stage by using the histological diagnosis and alanine-aminotransferase (ALT) level as well as with the presence of HCV RNA in the serum and viral protein of the liver. Such comparison of data and the use of the correlation analysis made it possible to establish that the antibodies to NS5 protein were detected reliably more often in patients with a more pronounced hepatic fibrosis, with a higher ALT activity and with expression of HCV proteins in the liver. At the same time, the presence of proteins in the liver and of RNA in the serum were accompanied by a more active humoral response to the non-structure proteins of NS4 and NS5 as well as by more profound discrepancies of the immunity T-cell chain (a lowered ratio of CD47 CD8* and a smaller content of CD95*). There were no differences between PBL of the studied populations in patients with various activities and an HCV stage. A relatively bigger quantity of CD95* - positive PBL was found to be reliably higher in patients with viremia but lower in those cases, in which HCV proteins were detected in the liver. This confirms the inhibiting ability of HCV proteins to the Fas-mediated apoptose of PBL in CHC patient.
References
- Абдулмеджидова А. Г., Масалова О. В., Атанадзе С. Н. и др. Характеристика панели моноклональных антител к рекомбинантному белку NS3 вируса гепатита С // Вопр. вирусол. - 2002. - № 1. - С. 21-25.
- Буеверов А. О., Тихонина Е. В., Москалева Е. Ю. и др. Апоптоз лимфоцитов и гранулоцитов периферической крови при хронических HBV- и HCV-инфекциях // Рос. журн. гастроэнтерол., гепатол., колопроктол. - 2000. - № 6. - С. 33-36.
- Круглов И. В., Знойно О. О., Огиенко О. Л. и др. Спектр антител к различным антигенам HCV при разных вариантах течения хронической HCV-инфекции // Вопр. вирусол. - 2002.-№ 2.-С. 11-15.
- Лакина Е. И., Самохвалов Е. И., Левченко О. Г. и др. Выявление позитивных (геномных) и негативных (репликативных) цепей РНК вируса гепатита С в сыворотке крови, лимфоцитах и ткани печени больных хроническим гепатитом С с помощью полимеразной цепной реакции // Там же. - 2000. - № 4. - С. 37-41.
- Масалова О. В., Лакина Е. И., Абдулмеджидова А. Г. и др. Исследование РНК ВГС и вирусспецифических белков в лимфоцитах периферической крови пациентов с хроническим гепатитом С // Гепатит В, С и D - проблемы диагностики, лечения и профилактики. - М., 2001. - С. 222- 223.
- Масалова О. В., Абдулмеджидова А. Г., Атанадзе С. Н. и др. Характеристика панели моноклональных антител и эпитопное картирование белков вируса гепатита С // Докл. АН. - 2002. - Т. 383, № 4. - С. 545-550.
- Antonaci S., Schiraldi О. Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favoring liver injury progression? A review // Immunopharmacol. and Immunotoxicol. - 1998. - Vol. 20. - P. 455-472.
- Beld M., Penning M., van Putten M. et al. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis С virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood // Hepatology. - 1999. Vol. 29. - P. 1288-1298.
- Boyer N., Marcellin P. Pathogenesis, diagnosis and management of hepatitis С // J. Hepatol. - 2000. - Vol. 32. - P. 98-112.
- Cramp M., Catucci P., Rossol S. et al. Hepatitis С virus (HCV) specific immune response in anti-HCV positive patients without hepatitis С viraemia // Gut. - 1999. - Vol. 44. - P. 424-429.
- Desmet V. J., Gerber M., Hoofnagle J. H. et al. Classification of chronic hepatitis: diagnosis, grading and staging // Hepatology. - 1994. - Vol. 19. - P. 1513-1520.
- Hahn C., Cho Y., Kang B. et al. The HCV Core protein acts as a positive regulator of Fas-mediated apoptosis in a human limphoblastoid T-cells line // Virology. - 2000. - Vol. 276. - P. 127-137.
- Machida K., Tsukiyama-Kohara K., Seike E. et al. Inhibition of cytochrome - release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis С viral proteins // J. Biol. Chem. - 2001. - Vol. 276. - P. 12140-12146.
- Marusawa H., Hijikata M., Chiba Т., Shimotohno K. Hepatitis С virus core protein inhibits Fas-mediated and TNF-alpha-mediated apoptosis via NF-Kappa-B activation // J. Virol. - 1999. - Vol. 73. - P. 4713-4720.
- Okamoto H., Okada S., Sugiyama Y. Detection of hepatitis С virus RNA by a two-stage polymerase chain reaction with two pairs of praimers deduced from the 5-noncoding region // Jpn. J. Exp. Med. - 1990. - Vol. 60. - P. 215-222.
- Rodrigues C. M., Brites D., Serejo F. et al. Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis С patients // J. Viral Hepatit. - 2000. - Vol. 7. - P. 175-183.
- Shaw S., Luse G. G., Gilks W. R. etal. Leucocyte differentiation antigen database // Leucocyte Typing / Ed. S. F. Schlossman. - Oxford, 1995. - P. 16-198.
- Tagashira M., Yamamoto K., Fujio K. et al. Expression of perforin and Fas ligand messenger RNA in the liver of viral hepatitis // J. Clin. Immunol. - 2000. - Vol. 20. - P. 347-353.
- Taya N., Torimoto Y., Shindo M. et al. Fas-mediated apoptosis of periferal blood mononuclear cells in patients with hepatitis С // Br. J. Haematol. - 2000. - Vol. 110. - P. 89-97.